Supplementary ExcelₙCounter PanCancer Human Pathways Panel Gene List from Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study | Synapse
October 7, 2024Open Access
Supplementary ExcelₙCounter PanCancer Human Pathways Panel Gene List from Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplementary ExcelₙCounter PanCancer Human Pathways Panel Gene List